Skip to content
Compounder
← Stocks

Option Care Health Inc

OPCHWithin bandExpectations · modest

Held by 2 superinvestors.

Price$23.64
Holders2
Total value$131.6M

SEC 10-K · fundamentals

Business quality

as of 2025-12-31

Valuation basis: trailing twelve months to 2026-03-31 — latest 10-K plus unaudited 10-Q filings.

Revenue growth
+15.0%
Net margin
3.7%
ROE
15.7%
FCF margin
3.8%
Revenue $3.03B → $5.65B · 6y
What makes a business high quality

Valuation · value band

In fair-value range

$23/ sh · growth-anchored intrinsic value
margin of safety
fair value
above fair value
$24
cheaperpricier

Zero-growth floor

$12

Central IV

$23

Optimistic top

$35

Option Care Health Inc (OPCH): Two methods value the business — a conservative owner-earnings DCF and a growth-credited Greenwald estimate, $12–$35 / sh. Today’s price sits inside both (price $24 as of 2026-08-25).

The middle figure is the main read. The right end is the optimistic case under the same conservative caps — not an absolute ceiling.

Revenue growth 7% (lower of historical trend and fundamental cap, capped by moat) · moat 10 yr · discount 11.1% · Zero-growth downside $12

Price as of 2026-08-25 · yahoo · DGS10 4.7% @ 2026-08-24.

Method & numbers

Model cautions

  • The two methods’ midpoints differ materially — growth assumptions warrant review (over 20%).

A conservative intrinsic-value band (zero-growth floor to growth-capped DCF) plus a tangible asset floor — not investment advice, not a buy/sell signal, and not a price target.

Owner-earnings DCF $14.66 – $27.94 · Greenwald $22.33 – $34.96 (neutral $28.29) · zero-growth base $16.41 · reproduction $2.51

Moat Franchise (moat) · terminal value 48% of present value · owner-earnings yield 7% vs 10Y 4.7%.

Graham earnings-power value (normalized NOPAT)$12.29 – $16.41 / sh

Normalized NOPAT = average operating margin over the years shown × latest-year revenue × (1 − normalized tax); then + D&A − maintenance capex (write A). Unlevered (pre-interest, attributable to all capital). Capitalized at the 9–11% rate band (read as a WACC proxy). Enterprise → equity bridge applied: + cash − total debt.

Years: TTM 2026-03-31, 2024, 2023, 2022, 2021

v1 simplifications: Maintenance capex (degraded) deducted in full cash (write A): EPV = (NOPAT + D&A − maintenance capex) / WACC; no tax shield on the capex term. Maintenance-capex methods diverge by 260% (> 50%); estimate is degraded. Share-based compensation is left as a real expense (not added back). Operating margin is below its multi-year average (cyclical/declining): normalized margin capped at the latest year — no peak-margin capitalization (audit #2).

Buffett owner-earnings value$13.37 – $16.18 / sh

Owner earnings = average net income + average D&A − maintenance capex (zero-growth floor; no ΔNWC). Levered (starts from net income, already after interest — an equity-holder stream). Capitalized at the 9.5–11.5% band (9–11% base + 0.5pp leverage premium). No enterprise→equity bridge: the capitalized result is already equity value (subtracting debt would double-count interest).

Years: TTM 2026-03-31, 2024, 2023, 2022, 2021

v1 simplifications: Owner earnings = net income + D&A − maintenance capex (degraded); the working-capital change is excluded (maintenance ΔNWC ≈ 0; growth ΔNWC is carried in growth value, not double-counted). Maintenance-capex methods diverge by 260% (> 50%); estimate is degraded. One-time items are not separately normalized (multi-year averaging smooths them partially). Share-based compensation is left as a real expense (not added back); see the SBC/OE disclosure. Capitalized at the 9–11% base band plus a 0.5pp leverage premium (cost of equity rises with leverage — MM Proposition II). Net debt is about 4.0 years of owner earnings, adding 0.5pp of cost-of-equity risk premium.

Asset floor: Reproduction value = tangible net assets + acquired-intangible reset proxy, ÷ diluted shares; tangible net assets alone are negative for this asset-light franchise (no R&D history to capitalize).

Moat reading: Franchise test compares earnings power (EPV) against reproduction value (tangible net assets + capitalized R&D). EPV well above reproduction value signals a moat; near it, a commodity; below it, value destruction. A directional reading, not a verdict.

Assumes a narrow moat · competitive-advantage period ≈ 10 years.

Growth value: if the moat holds for 10 yr at ROIIC ≈ 47%, $5.92–$18.55 / sh (neutral $11.88). Conservative, not a forecast.

Window TTM 2026-03-31, FY 2024, 2023, 2022, 2021 · discount band 9%–11% · normalized tax 17% (Average effective tax rate over 5 year(s), capped at the statutory 21%.) · diluted shares.

Baseline 9%–11%, net debt ≈ 4.0 years of owner earnings → +0.5pp cost-of-equity premium → effective 9.5%–11.5%.

Owner-earnings DCF: growth g₁ 7% · OE FY TTM 2026-03-31, 2024, 2023, 2022, 2021 · Discount band: 9.72%–12.52% (DGS10 +4.5% to a 12% strict end, each +0.52pp for leverage premium, as of 2026-08-24). No enterprise→equity bridge: owner earnings already flow to shareholders (post-interest), so no net cash is added and no debt subtracted — matching the engine owner-earnings lamp. Two-method midpoint gap 20%.

Valuation basis: trailing twelve months to 2026-03-31 — latest 10-K plus unaudited 10-Q filings.

What the price is betting

Today's price pencils in about 7.5% a year in owner-earnings for the next few years. Revenue actually grew 13.0% a year.

Below what it has already done.

Roughly, the price needs its historical revenue growth to run about 6 more years to hold up.

How to read intrinsic value

SEC 13F · holders

Superinvestors Holding This Security

2 holders · $131.6M combined · this quarter +1 opened / -1 exited

This quarter1 opened1 trimmed1 exited
Holders 3 → 2 · last 8q
Exited this quarter (1)
Stanley Druckenmiller

SEC 13F · notes

Written summary

Option Care Health Inc (OPCH) is held by 2 of the superinvestors tracked on Compounder, with a combined $131.6M in reported 13F value. The largest position belongs to Henry Ellenbogen, where it makes up 1.3% of the portfolio.

Other notable holders by value include Ray Dalio (0.0% of its book).

Over the latest quarter, 1 of the tracked filers opened a new position in OPCH, 0 added to existing ones, 1 trimmed, and 1 sold out entirely.

Holder counts and values reflect the most recent SEC Form 13F filings, through the quarter ended 2026-06-30. Source: SEC EDGAR. A 13F shows only long US-listed positions and can lag the real portfolio by up to 45 days, so this is disclosed long ownership, not a complete picture.

How to read a 13F

SEC 13F · co-ownership

Also held by these investors

Investors holding Option Care Health Inc (OPCH) also commonly hold →

OPCH's price is not below its conservative value band. See current strike-zone stocks

Also on

Sources· SEC EDGAR 13F as of 2026-06-30 · filed 2026-08-14

Educational data only — not investment advice. 13F positions are self-reported and can lag up to 45 days.

Stay Updated

New-quarter 13F moves and valuation updates, to your inbox.